- In the
management of Parkinson's disease, due to the
chronic nature of Parkinson's
disease (PD), a broad-based
program is
needed that
includes patient...
- with time. A 2024 meta-analysis of DBS
treatment in
conjunction with
antiparkinsonian drugs found improvements primarily in
motor function, with serious...
- that memantine,
along with amantadine, has been
widely used as an
antiparkinsonian agent since at
least 1994.
Although amantadine and
memantine have fairly...
-
reuptake inhibitor activity Budipine t-Bu Ph H Ph
Antiparkinsonian agent Prodipine iPr Ph H Ph
Antiparkinsonian agent Ketobemidone Me 3-HO–Ph H –COEt Opioid...
- Pronoran,
Trivastal ****, Trastal, Trivastan,
Clarium and others) is an
antiparkinsonian agent and
piperazine derivative which acts as a D2 and D3 receptor...
- purposes.
These include anesthetics, analgesics,
anticonvulsant and
antiparkinsonian drugs as well as
medications used to
treat neuropsychiatric disorders...
- C. G.; Klawans, H. L.; Thiessen, B. (1989). "Hyper****uality with
antiparkinsonian therapy".
Clinical Neuropharmacology. 12 (5): 375–383. doi:10...
- (R)-1-aminoindan, is
pharmacologically active and is an
active metabolite of the
antiparkinsonian agent rasagiline.
Through its (R)-enantiomer (R)-1-aminoindane, 1-aminoindane...
- for
prophylaxis against the
influenza virus A in 1966. In 1968, its
antiparkinsonian effects were
serendipitously discovered. In 1973, the Food and Drug...
-
Hypokinesia and rigidity,
especially in
juvenile cases, can be
treated with
antiparkinsonian drugs, and
myoclonic hyperkinesia can be
treated with
valproic acid...
